Balance Sheets (Unaudited) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current Assets
Cash	$ 4,933	$ 33,839
Due from government agency	1,050	1,077
Prepaid expenses and deposits	118,954	15,004
Deferred financing costs (Note 5)	25,084	37,452
Toatal ASSETS	150,021	87,372
Current Liabilities
Accounts payable and accrued liabilities (Note 12)	1,457,298	1,941,716
Research agreement obligations (Note 3)	492,365	415,998
Derivative liability – conversion option (Note 4)	195,300	867,575
Derivative liability – warrants (Note 4)	89,195	977,086
Convertible notes payable (Note 5)	2,348,756	1,376,230
Loans payable (Note 6)	10,000	10,000
Promissory notes (Note 7)	277,942	167,942
Due to related parties (Note 8)	381,846	373,346
Total Current Liabilities	5,252,702	6,129,893
Stockholders’ Deficit
Common stock, $0.001 par value, 150,000,000 shares authorized 144,308,515 shares issued and outstanding (2012 – 76,402,958)	142,410	76,404
Additional paid-in capital	46,381,379	43,483,947
Shares and warrants to be issued (Note 9)	384,343	352,859
Deficit accumulated during the development stage	(51,950,968)	(49,894,083)
Accumulated other comprehensive loss	(59,845)	(61,648)
Total Stockholders’ Deficit	(5,102,681)	(6,042,521)
Total LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 150,021	$ 87,372